Ingenia Therapeutics chairman Han Sang Yeul cuts stake to 74.60% from 76.80% in disclosure
Bitget2026/09/29 07:51- Ingenia Therapeutics largest shareholder Han Sang Yeul disclosed a reduced stake to 36,885,969 shares, or 74.6%, as of Sept. 29.
- Holding fell from 37,975,106 shares, or 76.8%, in the prior filing dated Aug. 25.
- Change reflected 1,089,137 shares sold via on-market transactions; the disclosure cited a change report triggered on Sept. 18.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
After acquiring SpotHero, Uber (UBER.US) makes its debut in the parking sector with a parking space reservation feature, initially available in 15 U.S. cities
Uber has launched a brand new parking space reservation feature, which marks its first step in the parking sector following its acquisition of the parking app SpotHero earlier this year.
Arbitrum will welcome a new propAMM
Crypto prices
More
